4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-067451
Chief Development Officer sold 7,060 shares at $74.31 ($524,653)
- Chief Development Officer acquired 7,060 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2025-05-06 | Option exercise 10b5-1 | +7,060 | $21.65 | $152,849 | 12,547 | D |
| Guyer William Chief Development Officer | 2025-05-06 | Sale 10b5-1 | −7,060 | $74.31 | $524,653 | 5,487 | D |
| Derivatives | |||||||
| Guyer William Chief Development Officer | 2025-05-06 | Option exercise · Stock option (right to buy) 10b5-1 | −7,060 | 442,262 | D | ||
| Open-market sales · 7,060 sh · avg $74.31 · $524,653 | |||||||
Loading xslF345X05/ownership.xml…